The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Open accessAbstract
We report seven patients, six from a single institution, who developed subacute limbic encephalitis initially considered of uncertain aetiology. Four patients presented with symptoms of hippocampal dysfunction (i.e. severe short-term memory loss) and three with extensive limbic dysfunction (i.e. confusion, seizures and suspected psychosis). Brain MRI and [(18)F]fluorodeoxyglucose (FDG)-PET complemented each other but did not overlap in 50% of the patients. Combining both tests, all patients had temporal lobe abnormalities, five with additional areas involved. In one patient, FDG hyperactivity in the brainstem that was normal on MRI correlated with central hypoventilation; in another case, hyperactivity in the cerebellum anticipated ataxia. All patients had abnormal CSF: six pleocytosis, six had increased protein concentration, and three of five examined had oligoclonal bands. A tumour was identified and removed in four patients (mediastinal teratoma, thymoma, thymic carcinoma and thyroid cancer) and not treated in one (ovarian teratoma). An immunohistochemical technique that facilitates the detection of antibodies to cell surface or synaptic proteins demonstrated that six patients had antibodies to the neuropil of hippocampus or cerebellum, and one to intraneuronal antigens. Only one of the neuropil antibodies corresponded to voltage-gated potassium channel (VGKC) antibodies; the other five (two with identical specificity) reacted with antigens concentrated in areas of high dendritic density or synaptic-enriched regions of the hippocampus or cerebellum. Preliminary characterization of these antigens indicates that they are diverse and expressed on the neuronal cell membrane and dendrites; they do not co-localize with VGKCs, but partially co-localize with spinophilin. A target autoantigen in one of the patients co-localizes with a cell surface protein involved in hippocampal dendritic development. All patients except the one with antibodies to intracellular antigens had dramatic clinical and neuroimaging responses to immunotherapy or tumour resection; two patients had neurological relapse and improved with immunotherapy. Overall, the phenotype associated with the novel neuropil antibodies includes dominant behavioural and psychiatric symptoms and seizures that often interfere with the evaluation of cognition and memory, and brain MRI or FDG-PET abnormalities less frequently restricted to the medial temporal lobes than in patients with classical paraneoplastic or VGKC antibodies. When compared with patients with VGKC antibodies, patients with these novel antibodies are more likely to have CSF inflammatory abnormalities and systemic tumours (teratoma and thymoma), and they do not develop SIADH-like hyponatraemia. Although most autoantigens await characterization, all share intense expression by the neuropil of hippocampus, with patterns of immunolabelling characteristic enough to suggest the diagnosis of these disorders and predict response to treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,123
Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 897
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 771
Self-citationPotassium channel antibodies in two patients with reversible limbic encephalitis
Buckley, C., Oger, J., Clover, L., Tüzün, E., Carpenter, K., Jackson, M., & Vincent, A. (2001) · Annals of Neurology · doi:10.1002/ana.1097 · Cited by 444
Liguori, R. (2001) · Brain · doi:10.1093/brain/124.12.2417 · Cited by 407
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., & Vernino, S. (2004) · Neurology · doi:10.1212/01.wnl.0000122648.19196.02 · Cited by 394
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies
Rojas-Marcos, I., Graus, F., Keime-Guibert, F., Reñé, R., Delattre, J., Ramon, J. M., Dalmau, J. O., & Posner, J. B. (2000) · Neurology · doi:10.1212/wnl.55.5.713 · Cited by 323
Self-citationLimbic encephalitis and small cell lung cancer. Clinical and immunological features
Alamowitch, S. (1997) · Brain · doi:10.1093/brain/120.6.923 · Cited by 278
Dalmau, J. O., Furneaux, H., Cordon‐Cardo, C., & Posner, J. B. (1992) · PubMed · Cited by 259
Self-citationVoltage‐gated potassium channel antibodies in limbic encephalitis
Pozo‐Rosich, P., Clover, L., Saiz, A., Vincent, A., & Graus, F. (2003) · Annals of Neurology · doi:10.1002/ana.10713 · Cited by 173
Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis
Bernal, F., Graus, F., Pifarré, À., Saiz, A., Benyahia, B., & Ribalta, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0498-0 · Cited by 171
Law, A. J., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & Harrison, P. J. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1848 · Cited by 165
Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies
Benyahia, B., Liblau, R., Merle-B�ral, H., Tourani, J. M., Dalmau, J. O., & Delattre, J. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<162::aid-ana5>3.0.co;2-r · Cited by 158
Self-citationAutoantigen diversity in the opsoclonus‐myoclonus syndrome
Bataller, L., Rosenfeld, M. R., Graus, F., Vilchez, J. J., Cheung, N. V., & Dalmau, J. O. (2003) · Annals of Neurology · doi:10.1002/ana.10462 · Cited by 144
Self-citationLimbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy
Bien, C. G., Schulze‐Bonhage, A., Deckert, M., et al. (2000) · Neurology · doi:10.1212/wnl.55.12.1823 · Cited by 129
Buchhalter, J., & Dichter, M. A. (1991) · Brain Research Bulletin · doi:10.1016/0361-9230(91)90003-3 · Cited by 90
Self-citationARF6‐dependent interaction of the TWIK1 K+ channel with EFA6, a GDP/GTP exchange factor for ARF6
Decressac, S., Franco, M., Bendahhou, S., Warth, R., Knauer, S., Barhanin, J., Lazdunski, M., & Lesage, F. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400292 · Cited by 81
FDG-PET Findings in Patients With Suspected Encephalitis
Lee, B. Y., Newberg, A. B., Liebeskind, D. S., Kung, J. W., & Alavi, A. A. (2004) · Clinical Nuclear Medicine · doi:10.1097/00003072-200410000-00004 · Cited by 70
Self-citationDadparvar, S., Anderson, G. S., Bhargava, P., Guan, L., Reich, P., Alavi, A. A., & Zhuang, H. (2003) · Clinical Nuclear Medicine · doi:10.1097/01.rlu.0000093284.54060.aa · Cited by 55
Self-citationSakagami, H., Matsuya, S., Nishimura, H., Suzuki, R., & Kondo, H. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03195.x · Cited by 42
Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes
Lladó, A., Mannucci, P. M., Carpentier, A. F., Paris, S., Blanco, Y., Saiz, A., Delattre, J., & Graus, F. (2004) · Neurology · doi:10.1212/01.wnl.0000144340.03364.bf · Cited by 40
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationParaneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Self-citationIrani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A. (2010) · Brain · doi:10.1093/brain/awq213 · Cited by 1,359
Irani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035
Metadata
- Authors
- Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A., Houghton, D. J., Galetta, S. L., Dichter, M., Alavi, A., Rosenfeld, M. R., & Dalmau, J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-11
- Volume
- 128
- Issue
- 8
- Pages
- 1764-1777
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2114935132
- Cited by
- 488
- References
- 22
- FWCI
- 13.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.